Tag: Cancer: Breast
More Research Needed on Preventive Service Use by People With Disabilities
Review looks at data regarding barriers to and facilitators of breast and cervical cancer screening among people with disabilities
Female Breast Cancer Mortality Has Stopped Declining in Certain Age Groups
Decline in mortality rates seen from 1990 to 2022 for women aged 40 to 74 years for all cohorts except Asian women
Chemo Tied to Long-Lasting Physical Health Decline for Breast Cancer Survivors
Physical health decline greater for survivors receiving chemotherapy compared with endocrine therapy alone within two years of diagnosis
Breast Cancer Incidence Rates Vary by Region in U.S. Women Younger Than 40
Western region had highest rate of increase, despite having lowest absolute incidence rate from 2001 to 2020
Stressors Affect Systemic Inflammation, Tumor Aggressiveness in Breast Cancer
Perceived stress, discrimination, neighborhood deprivation linked to systemic inflammation, aggressive tumor characteristics
2.3 Million New Female Breast Cancer Cases Seen Globally in 2022
New cases and deaths set to increase by 38 and 68 percent by 2050, disproportionately affecting low-HDI countries
AI Contributes to Early Detection of Clinically Relevant Breast Cancer
Increase seen in detection of invasive cancers and in situ cancers, with reduction in screen-reading workload
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
Adding nivolumab to neoadjuvant chemotherapy significantly increases pathological complete response rates
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
Approval is targeted for patients with HER2-low or HER2-ultralow metastatic breast cancer with disease progression after endocrine therapy
FDA Approves Datroway for HR-Positive, HER2-Negative Breast Cancer
Approval is for those who have had prior therapy for unresectable or metastatic disease
